PL1937212T3 - Emulsje oftalmiczne zawierające prostaglandyny - Google Patents
Emulsje oftalmiczne zawierające prostaglandynyInfo
- Publication number
- PL1937212T3 PL1937212T3 PL06806156T PL06806156T PL1937212T3 PL 1937212 T3 PL1937212 T3 PL 1937212T3 PL 06806156 T PL06806156 T PL 06806156T PL 06806156 T PL06806156 T PL 06806156T PL 1937212 T3 PL1937212 T3 PL 1937212T3
- Authority
- PL
- Poland
- Prior art keywords
- sub
- emulsions containing
- prostaglandins
- emulsions
- oily core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2005/011648 WO2006050836A2 (en) | 2004-11-09 | 2005-10-10 | Ophthalmic emulsions containing prostaglandins |
EP06806156A EP1937212B1 (en) | 2005-10-10 | 2006-10-10 | Ophthalmic emulsions containing prostaglandins |
PCT/EP2006/009783 WO2007042262A2 (en) | 2005-10-10 | 2006-10-10 | Ophthalmic emulsions containing prostaglandins |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1937212T3 true PL1937212T3 (pl) | 2011-02-28 |
Family
ID=37600871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06806156T PL1937212T3 (pl) | 2005-10-10 | 2006-10-10 | Emulsje oftalmiczne zawierające prostaglandyny |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1937212B1 (pl) |
JP (1) | JP5247453B2 (pl) |
KR (1) | KR101286807B1 (pl) |
CN (1) | CN101282714B (pl) |
AT (1) | ATE479424T1 (pl) |
AU (1) | AU2006301493B2 (pl) |
CA (1) | CA2625568C (pl) |
DE (1) | DE602006016628D1 (pl) |
DK (1) | DK1937212T3 (pl) |
ES (1) | ES2351358T3 (pl) |
PL (1) | PL1937212T3 (pl) |
PT (1) | PT1937212E (pl) |
WO (1) | WO2007042262A2 (pl) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1985298A1 (en) * | 2007-04-24 | 2008-10-29 | Azad Pharma AG | Ophtalmic oil-in-water emulsions containing prostaglandins |
US8512687B2 (en) | 2007-07-09 | 2013-08-20 | Novagali Pharma Sa | Oil in water emulsion comprising NSAIDs and quaternary ammonium halides |
CA2730221C (en) * | 2007-07-09 | 2016-02-02 | Novagali Pharma Sa | Oil in water emulsion comprising nsaids and quaternary ammonium halides |
DE602007009213D1 (de) * | 2007-07-09 | 2010-10-28 | Novagali Pharma Sa | är Ammoniumhalogenide |
EP2044951A1 (en) | 2007-10-02 | 2009-04-08 | Merz Pharma GmbH & Co. KGaA | The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases |
EP2229174A1 (en) * | 2007-12-04 | 2010-09-22 | Novagali Pharma S.A. | Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
EP2127638A1 (en) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
EP2228057A1 (en) * | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
EP2228058A1 (en) * | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Anionic oil-in-water emulsion containing prostaglandins and uses thereof |
US8501800B2 (en) * | 2009-03-05 | 2013-08-06 | Insite Vision Incorporated | Controlled-release ophthalmic vehicles |
CA2773597A1 (en) * | 2009-09-17 | 2011-03-24 | Senju Pharmaceutical Co., Ltd. | Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin |
EP2389939A1 (en) | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
SI2598118T1 (sl) * | 2010-07-29 | 2018-12-31 | Allergan, Inc. | Raztopine z bimatoprostom in timololom brez konzervansov |
WO2013025696A1 (en) * | 2011-08-15 | 2013-02-21 | Teva Pharmaceutical Industries Ltd. | Ophthalmic formulations and processes for their preparation |
EP2567689A1 (en) | 2011-09-12 | 2013-03-13 | Visiotact Pharma | Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid |
CN103957875A (zh) * | 2011-10-05 | 2014-07-30 | 阿勒根公司 | 用于增强指甲健康的组合物 |
US10092549B2 (en) * | 2013-03-14 | 2018-10-09 | Panoptica, Inc. | Ocular formulations for drug-delivery to the posterior segment of the eye |
KR20150000405A (ko) * | 2013-06-24 | 2015-01-02 | 한국콜마주식회사 | 난용성 의약품의 수중유적형 에멀젼 조성물 및 이의 제조방법 |
EP3013790A1 (en) | 2013-06-27 | 2016-05-04 | Mylan Laboratories Ltd. | Process for the preparation of nepafenac |
WO2016013993A1 (en) | 2014-07-25 | 2016-01-28 | Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. | Stable preservative free ophthalmic formulations of opioid antagonists |
JP6404785B2 (ja) * | 2015-08-12 | 2018-10-17 | 日本電信電話株式会社 | 生体分子移動度制御方法および電気泳動槽 |
CN109498597B (zh) * | 2018-12-07 | 2021-12-14 | 佛山市正典生物技术有限公司 | 一种喹烯酮微丸及其制备方法 |
JP6855026B1 (ja) * | 2020-11-09 | 2021-04-07 | 東亜薬品株式会社 | タフルプロスト点眼液 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0818989B2 (ja) * | 1984-01-12 | 1996-02-28 | 株式会社ミドリ十字 | 脂肪乳剤中のプロスタグランジンの安定化方法 |
JP2602964B2 (ja) * | 1989-10-16 | 1997-04-23 | 裕 水島 | プロスタグランジン類縁体およびその脂肪乳剤 |
IL101241A (en) * | 1992-03-16 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier |
US6011062A (en) * | 1994-12-22 | 2000-01-04 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
ES2343512T3 (es) | 2001-11-01 | 2010-08-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Procedimiento y composicion para el tratamiento del ojo seco. |
KR100446960B1 (ko) * | 2001-12-04 | 2004-09-01 | 김종국 | 프로스타글란딘 e1을 포함하는 온도감응성 에멀젼 외용제조성물 |
US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
WO2005044276A1 (ja) * | 2003-11-07 | 2005-05-19 | Senju Pharmaceutical Co., Ltd. | プロスタグランジン含有医薬組成物 |
-
2006
- 2006-10-10 DK DK06806156.3T patent/DK1937212T3/da active
- 2006-10-10 KR KR1020087008587A patent/KR101286807B1/ko active IP Right Grant
- 2006-10-10 AU AU2006301493A patent/AU2006301493B2/en active Active
- 2006-10-10 ES ES06806156T patent/ES2351358T3/es active Active
- 2006-10-10 PT PT06806156T patent/PT1937212E/pt unknown
- 2006-10-10 DE DE602006016628T patent/DE602006016628D1/de active Active
- 2006-10-10 EP EP06806156A patent/EP1937212B1/en active Active
- 2006-10-10 JP JP2008533955A patent/JP5247453B2/ja active Active
- 2006-10-10 CA CA2625568A patent/CA2625568C/en active Active
- 2006-10-10 AT AT06806156T patent/ATE479424T1/de not_active IP Right Cessation
- 2006-10-10 WO PCT/EP2006/009783 patent/WO2007042262A2/en active Application Filing
- 2006-10-10 CN CN2006800375133A patent/CN101282714B/zh active Active
- 2006-10-10 PL PL06806156T patent/PL1937212T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007042262A2 (en) | 2007-04-19 |
EP1937212B1 (en) | 2010-09-01 |
EP1937212A2 (en) | 2008-07-02 |
JP2009511442A (ja) | 2009-03-19 |
DK1937212T3 (da) | 2010-12-13 |
ES2351358T3 (es) | 2011-02-03 |
ATE479424T1 (de) | 2010-09-15 |
KR20080066675A (ko) | 2008-07-16 |
CA2625568C (en) | 2013-10-08 |
PT1937212E (pt) | 2010-11-30 |
KR101286807B1 (ko) | 2013-07-23 |
AU2006301493A1 (en) | 2007-04-19 |
WO2007042262A3 (en) | 2007-08-16 |
CN101282714B (zh) | 2012-12-12 |
AU2006301493B2 (en) | 2013-01-10 |
JP5247453B2 (ja) | 2013-07-24 |
CA2625568A1 (en) | 2007-04-19 |
CN101282714A (zh) | 2008-10-08 |
DE602006016628D1 (de) | 2010-10-14 |
WO2007042262A8 (en) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1937212T3 (pl) | Emulsje oftalmiczne zawierające prostaglandyny | |
WO2006050836A3 (en) | Ophthalmic emulsions containing prostaglandins | |
BR9808016A (pt) | Composições e métodos para redução da hipertensão ocular | |
MX2007005545A (es) | Emulsion oftalmica tipo aceite en agua con potencial zeta positivo estable. | |
RU2009143324A (ru) | Офтальмические эмульсии масло-в-воде, содержащие простагландины | |
ES2161895T3 (es) | Emulsiones especificas de la glandula lagrimal para aplicacion topica a tejidos oculares. | |
US9539262B2 (en) | Ophthalmic composition comprising a prostaglandin | |
JP2010524992A5 (pl) | ||
KR20120135011A (ko) | 안과용 조성물 | |
KR20120092650A (ko) | 안과용 에멀젼 | |
NZ560788A (en) | Ophthalmic solution comprising bimatoprost and benzalkonium chloride | |
CO5570649A2 (es) | Producto antitranspirante en gel liquido de alta eficiencia | |
WO2007059888A3 (en) | Oil-in-water emulsions based on special emulsifiers | |
RU2011143860A (ru) | Безфосфатный лекарственный препарат для лечения глаукомы | |
JP2014515383A5 (pl) | ||
FR3108843B1 (fr) | Composition cosmétique pour soin de la peau | |
JP3846537B2 (ja) | コンタクトレンズ用装着液 | |
JP4072119B2 (ja) | 安定化された透明な香料エマルション | |
JPWO2006009101A1 (ja) | コンタクトレンズ用装着液 | |
DE602006001226D1 (de) | Schäumende O/W-Emulsion und ihre Verwendung in der Kosmetik | |
JP2001187733A5 (pl) | ||
AR036467A1 (es) | Composiciones acondicionadoras para telas | |
RU2009120545A (ru) | Модуляторы связывания pai-1 для лечения глазных болезней | |
JP2007070350A (ja) | 眼粘膜適用製剤 | |
JP2009040727A (ja) | ラタノプロストを有効成分とする安定な点眼液剤 |